NANCY HAM
CIK 1124500 · last filed 2025-09-11
NANCY HAM is a corporate insider who has filed 11 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing shows the insider sold $49.0K of USPH on Sep 11, 2025. Across all open-market trades the lifetime net is −$272.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $130.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$130.7K
2
11
-$272.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| USPH | Director | 1,994 | $65.56 | $130.7K | -$272.9K | 8 | 2025-09-11 |
| NxStage Medical, Inc. (NXTM) Delisted | Director | — | — | — | $0 | 3 | 2012-05-25 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-11 | USPH | Sell (S) | −600 | -$49.0K | EDGAR |
| 2025-06-13 | USPH | Sell (S) | −400 | -$31.2K | EDGAR |
| 2025-05-21 | USPH | Grant (A) | +1,882 | $0 | EDGAR |
| 2024-11-12 | USPH | Sell (S) | −1,172 | -$113.4K | EDGAR |
| 2024-05-21 | USPH | Grant (A) | +1,424 | $0 | EDGAR |
| 2024-03-14 | USPH | Sell (S) | −500 | -$53.9K | EDGAR |
| 2023-08-16 | USPH | Sell (S) | −240 | -$25.4K | EDGAR |
| 2023-05-26 | USPH | Grant (A) | +1,600 | $0 | EDGAR |
| 2012-05-25 | NxStage Medical, Inc. (NXTM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-27 | NxStage Medical, Inc. (NXTM) Delisted | Grant (A) | — | $0 | EDGAR |